logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fei Liu

Yangtze University
H指数:18
被引数:1,201

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial
BMJ OPEN
IF2.3
2025-11-050
PRE
Li, Qianqian; Tong, Huan; Liu, Xuemei; Liao, Fei; Ma, Han; Zhou, Zhihang; Liu, Fei; Shi, Haitao; Wang, Zhongfeng; Sun, Yang; Yao, Qunyan; Feng, Yan; Li, Ximei; Feng, Jing; He, Zhoutao; Peng, Ya; Bai, Zhaohui; Zhu, Rong; Cheng, Du; Xu, Chengfu; He, Song; Yu, Huihong; Xie, Chen; Yuan, Jia; Wang, Xinrui; Yang, Hongju; Zou, Yanting; Li, Shuyu; Li, Ting; Hu, Shengjuan; Chen, Chaochao; Chen, Zhiyuan; Lantinga, Marten A.; Bernardi, Mauro; Qi, Xingshun; Tang, Chengwei
The Positive Feedback of lncRNA ANRIL/miRNA-339-5p/ZBTB7A Suppresses Metastasis of Nasopharyngeal Carcinoma Cells via SREBP1-FASN

lncRNA ANRIL/miRNA-339-5p/ZBTB7A的正反馈抑制鼻咽癌细胞转移，其机制是通过SREBP1-FASN通路。

Cancer Science
IF4.3
2025-10-280
OAAI
Fei Liu; Jiazhang Wei; Suosu Wei; Mingzheng Mo; Jiao Lan; Jingjin Weng; Ruiping Xiao; Cheng Su; Weiming Deng; Yujuan Huang; Bing Li; Min Li; Le Shi; Yuanjun Zhan; Yunhua Peng; Yongli Wang; Fengzhu Tang; Huadong Liu; Shenhong Qu; Jiangang Long
Safety and tolerability of bireociclib for the treatment of advanced solid tumors as monotherapy and in combination with endocrine therapy: a multicenter, open-label, phase 1 clinical trial

比卡鲁胺单药治疗及联合内分泌疗法治疗晚期实体瘤的安全性和耐受性：一项多中心、开放标签、I期临床试验

BMC Medicine
IF8.3
2025-10-100
OAAI
Jiayu Wang; Tao Sun; Zhongsheng Tong; Xichun Hu; Wei Li; Min Yan; Yunjiang Liu; Quchang Ouyang; Xiaoqing Liu; Jian Fang; Huiping Li; Hui Li; Wenyan Chen; Chang Gong; Yuee Teng; Lingmei Xu; Xianghui Duan; Mingming Liu; Yaping Meng; Fei Liu; Li Wang; Binghe Xu
Bireociclib plus fulvestrant for HR+/HER2-advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis

Birtociclib 联合 fulvestrant 治疗 HR+/HER2- 经内分泌治疗后进展的晚期女性乳腺癌：BRIGHT-2 研究 III 期中期分析

NATURE COMMUNICATIONS
IF15.7
2025-04-090
OA
Wang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Shu; Wang, Xinshuai; Wu, Xinhong; Liu, Ning; Yu, Guohua; Liu, Fei; Duan, Xianghui; Wang, Shuya; Meng, Yaping; Wang, Li

研究方向

暂未获取到该数据
J
Jingjin Weng
H 指数:11论文数:49被引数:296
S
Shenhong Qu
H 指数:15论文数:104被引数:1,772
J
Jinyan Zhang
H 指数:30论文数:233被引数:3,437
Y
Yue Luo
H 指数:20论文数:72被引数:1,745
S
Suosu Wei
H 指数:9论文数:47被引数:263
J
Jiaxiang Ye
H 指数:13论文数:34被引数:512
J
Jiao Lan
H 指数:24论文数:99被引数:2,087
J
Jiazhang Wei
H 指数:0论文数:4被引数:0
H 指数:0论文数:71被引数:0
王
王俐
H 指数:87论文数:1,389被引数:3.2万